Funding Agency

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Research Project--Cooperative Agreements (U01)
Project #
4U01FD004575-04
Application #
8921828
Study Section
Special Emphasis Panel (ZFD1-SRC (99))
Project Start
2012-09-05
Project End
2017-08-31
Budget Start
2015-09-01
Budget End
2016-08-31
Support Year
4
Fiscal Year
2015
Total Cost
$250,000
Indirect Cost

  Institution

Name
World Health Organization
Department
Type
DUNS #
480997543
City
Geneva
State
Country
Switzerland
Zip Code
1211

  Publications

Bravo-Alcántara, Pamela; Pérez-Vilar, Silvia; Molina-León, Helvert Felipe et al. (2018) Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network. Vaccine 36:363-370
Stuurman, Anke L; Riera, Margarita; Lamprianou, Smaragda et al. (2018) Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment. Vaccine 36:6736-6743
Perez-Vilar, Silvia; Weibel, Daniel; Sturkenboom, Miriam et al. (2018) Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination. Vaccine 36:347-354